Quantcast

Latest Hypolipidemic agent Stories

2008-09-03 07:30:00

By Steve Sternberg The editors of a leading medical journal cautioned Tuesday that, without more data, it's impossible to rule out a link between the cholesterol-lowering drug Vytorin and cancer. The cancer link surfaced unexpectedly in July in three studies designed to show whether the drug prevents deaths from heart attacks and strokes. Researchers found evidence that patients who took Vytorin appear to have at least a 40% greater risk of dying from cancer than those who took a placebo. A...

2008-09-03 00:00:24

An editorial in the New England Journal of Medicine says more study is needed of the cholesterol-lowering drugs Zetia and Vytorin. Researchers reported last month that patients in three clinical trials had a 40 percent higher chance of dying of cancer if they took Vytorin instead of a placebo, the New York Times reported Tuesday. Vytorin is a combination drug containing ezetimibe, the generic name for Zetia. Drug makers Merck and Schering-Plough say ezetimibe showed no cancer risk in...

2008-07-25 06:00:18

By Steve Sternberg A study that unexpectedly linked the heart drug Vytorin to excess cancer deaths has provoked controversy among heart specialists worried that the drug's risks may outweigh its benefits. The study, called SEAS, was designed to test whether Vytorin could prevent severe, age-related heart valve problems by sharply reducing cholesterol. But lead investigator Terje Pedersen of Ulleval University Hospital in Oslo reported Monday that the study turned up a "disturbing" link...

2008-07-24 15:00:15

By ALICIA CHANG, THE ASSOCIATED PRESS Scientists may have found a way to test for and possibly avoid the most serious side effect of cholesterol-lowering statin drugs, one of the top-selling medicines in the world. In rare cases, statins can cause muscle pain and weakness. Researchers have identified a genetic variation that seems to predict more than half of these cases. People on statins who have the variant were about five to 17 times more likely to develop muscle problems, a serious...

2008-07-23 15:00:31

By JANJARVIS FORT WORTH, Texas - Beverly Morgan of Arlington, Texas, was 16 when she started taking the popular cholesterol-lowering drug Vytorin. But she eventually abandoned the medication. "I would rather control my cholesterol with exercise and diet simply because when you do put drugs in your body, you're going to have side effects," said Morgan, 19, a student at Mountain View Community College in Dallas. "I try to take as little medications as possible." While many people share...

2008-07-22 00:00:16

By Jan Jarvis FORT WORTH, Texas - Beverly Morgan of Arlington, Texas, was 16 when she started taking the popular cholesterol-lowering drug Vytorin. However, she eventually abandoned the medication. "I would rather control my cholesterol with exercise and diet, simply because when you do put drugs in your body, you're going to have side effects," said Morgan, 19, a student at Mountain View Community College in Dallas. "I try to take as little medications as possible." While many people...

2008-07-17 15:01:02

The American Academy of Pediatrics (AAP) released new guidelines on July 7, 2008, recommending that some children as young as 8 years old be given cholesterol-fighting drugs to ward off future heart problems. It is the strongest guidance ever given by the AAP. Madeira Therapeutics, a pediatric drug-development company, currently has a statin, a cholesterol-lowering product, in the development pipeline focused on this need. The new guidelines set by the AAP are based on evidence showing that...

2008-07-14 09:00:14

My daughter Kaitlyn is 8 years old. According to the American Academy of Pediatrics, she's ready for cholesterol-lowering drugs. Yes, you read that right. In a move that has left many parents incredulous, the nation's pediatricians recently issued new guidelines calling for cholesterol screening of children as young as 2 _ and cholesterol drugs for kids as young as 8. Without intervention, the doctors say, today's overweight youngsters are doomed to become tomorrow's heart patients. Do we...

2008-07-11 09:00:15

By Jan Jarvis?, Fort Worth Star-Telegram, Texas Jul. 11--Beverly Morgan of Arlington was 16 when she started taking the popular cholesterol-lowering drug Vytorin. But she eventually abandoned the medication. "I would rather control my cholesterol with exercise and diet simply because when you do put drugs in your body, you're going to have side effects," said Morgan, 19, a student at Mountain View Community College in Dallas. "I try to take as little medications as possible." While...

2008-07-08 06:00:00

By Tara Parker Pope U.S. pediatricians are recommending wider cholesterol screening for children and more aggressive use of cholesterol-lowering drugs starting as early as the age of 8 in hopes of preventing adult heart problems. The new guidelines, issued Monday by the American Academy of Pediatrics, also call for giving children low-fat milk after 12 months of age. The push to aggressively screen and medicate for high cholesterol in children is certain to incite controversy amid a...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related